Julie Auwercx

Ms. Julie Auwercx

Laboratoire de Physiologie Cellulaire et Moléculaire (LPCM) - EA 4667
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JAJulie Auwercx
Julie Auwercx
PRPierre RYBARCZYK
Pierre RYBARCZYK
PKPhilippe Kischel
Philippe Kischel
IDIsabelle Dhennin
Isabelle Dhennin
DCDenis Chatelain
Denis Chatelain
Mathieu GautierMathieu Gautier
Mathieu Gautier
Despite magnesium (Mg2+) representing the second most abundant cation in the cell, its role in cellular physiology and pathology is far from being elucidated. Mg2+ homeostasis is regulated by Mg2+ transporters including Mitochondrial RNA Splicing Protein 2 (MRS2), Transient Receptor Potential Cation Channel Subfamily M, Member 6/7 (TRPM6/7), Magnesium Transporter 1 (MAGT1), Solute Carrier Family 41 Member 1 (SCL41A1), and Cyclin and CBS Domain Divalent Metal Cation Transport Mediator (CNNM) proteins. Recent data show that Mg2+ transporters may regulate several cancer cell hallmarks. In this review, we describe the expression of Mg2+ transporters in digestive cancers, the most common and deadliest malignancies worldwide. Moreover, Mg2+ transporters’ expression, correlation and impact on patient overall and disease-free survival is analyzed using Genotype Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) datasets. Finally, we discuss the role of these Mg2+ transporters in the regulation of cancer cell fates and oncogenic signaling pathways.

9 November 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Nicolas JonckheereNicolas Jonckheere
Nicolas Jonckheere
JAJulie Auwercx
Julie Auwercx
EBElsa Hadj Bachir
Elsa Hadj Bachir
LCLucie Coppin
Lucie Coppin
NBNihad Boukrout
Nihad Boukrout
Isabelle Van SeuningenIsabelle Van Seuningen
Isabelle Van Seuningen
Mucins are commonly associated with pancreatic ductal adenocarcinoma (PDAC) that is a deadly disease because of the lack of early diagnosis and efficient therapies. There are 22 mucin genes encoding large O-glycoproteins divided into two major subgroups: membrane-bound and secreted mucins. We investigated mucin expression and their impact on patient survival in the PDAC dataset from The Cancer Genome Atlas (PAAD-TCGA). We observed a statistically significant increased messenger RNA (mRNA) relative level of most of the membrane-bound mucins (MUC1/3A/4/12/13/16/17/20), secreted mucins (MUC5AC/5B), and atypical mucins (MUC14/18) compared to normal pancreas. We show that MUC1/4/5B/14/17/20/21 mRNA levels are associated with poorer survival in the high-expression group compared to the low-expression group. Using unsupervised clustering analysis of mucin gene expression patterns, we identified two major clusters of patients. Cluster #1 harbors a higher expression of MUC15 and atypical MUC14/MUC18, whereas cluster #2 is characterized by a global overexpression of membrane-bound mucins (MUC1/4/16/17/20/21). Cluster #2 is associated with shorter overall survival. The patient stratification appears to be independent of usual clinical features (tumor stage, differentiation grade, lymph node invasion) suggesting that the pattern of membrane-bound mucin expression could be a new prognostic marker for PDAC patients.

21 July 2022 in Cells
Verified
Journal Article
Open access
PDF file
JAJulie Auwercx
Julie Auwercx
PKPhilippe Kischel
Philippe Kischel
TLThibaut Lefebvre
Thibaut Lefebvre
Nicolas JonckheereNicolas Jonckheere
Nicolas Jonckheere
AVAlison Vanlaeys
Alison Vanlaeys
Mathieu GautierMathieu Gautier
Mathieu Gautier
Pancreatic diseases, such as pancreatitis or pancreatic ductal adenocarcinoma, are characterized by the presence of activated pancreatic stellate cells (PSCs). These cells represent key actors in the tumor stroma, as they actively participate in disease development and progression: reprograming these PSCs into a quiescent phenotype has even been proposed as a promising strategy for restoring the hallmarks of a healthy pancreas. Since TRPM7 channels have been shown to regulate hepatic stellate cells proliferation and survival, we aimed to study the role of these magnesium channels in PSC activation and proliferation. PS-1 cells (isolated from a healthy pancreas) were used as a model of healthy PSCs: quiescence or activation were induced using all-trans retinoic acid or conditioned media of pancreatic cancer cells, respectively. The role of TRPM7 was studied by RNA silencing or by pharmacological inhibition. TRPM7 expression was found to be correlated with the activation status of PS-1 cells. TRPM7 expression was able to regulate proliferation through modulation of cell cycle regulators and most importantly p53, via the PI3K/Akt pathway, in a magnesium-dependent manner. Finally, the analysis of TCGA database showed the overexpression of TRPM7 in cancer-associated fibroblasts. Taken together, we provide strong evidences that TRPM7 can be considered as a marker of activated PSCs.

24 April 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JAJulie Auwercx
Julie Auwercx
BNBernadette Neve
Bernadette Neve
AVAlison Vanlaeys
Alison Vanlaeys
MFMathilde Fourgeaud
Mathilde Fourgeaud
IBIngrid Bourrin-Reynard
Ingrid Bourrin-Reynard
Mathieu GautierMathieu Gautier
Mathieu Gautier
Pancreatic ductal adenocarcinoma (PDAC) is the main and the deadliest form of pancreatic cancer. This is a major problem of public health since it will become the second leading cause of death by cancer in the next few years, mainly due to the lack of efficient therapies. Transient Receptor Potential Cation Channel Subfamily M Member 7 (TRPM7) protein, a cation channel fused with a serine/threonine kinase domain is overexpressed in PDAC and associated with a low survival. In this work, we aim to study the role of kinase domain on pancreatic cell fates by using a model of kinase domain deletion by CRISPR-Cas9. PANC-1 and MIA PaCa-2 PDAC cell lines were used and kinase domain was deleted by CRISPR-Cas9 strategy. Kinase domain deletion (ΔK) was validated by RT-qPCR and western blots. The effect of kinase domain deletion on channel function was studied by patch-clamp and Mn2+-quenching. The cell phenotype was studied by MTT and cell migration/invasion assays. Finally, the role of kinase domain was studied in vivo in xenografted mice. Here we show that TRPM7 kinase domain is required to maintain a mesenchymal phenotype in PDAC cells. We also demonstrated that TRPM7 and PAK1 interact in the same protein complexes. Moreover, TRPM7 kinase domain is required for carcinogenesis and cancer cell dissemination in vivo. Intriguingly, the role of TRPM7 kinase is cell specific and may depend on the KRAS oncogene mutation status. In conclusion, TRPM7 kinase domain is required to maintain a mesenchymal and aggressive phenotype in PDAC cells, and it could be a promising target against PDAC.

9 October 2026
Verified
Thesis
Closed access
JAJulie Auwercx
Julie Auwercx
Le cancer du pancréas est l'un des cancers les plus mortels dans le monde. Ce faible taux de survie s'explique en partie par la capacité des cellules cancéreuses pancréatiques à former des métastases. La migration et l'invasion cellulaires sont des étapes fondamentales de la cascade métastatique, et la compréhension de ces mécanismes est donc cruciale. Dans ce cadre, la protéine TRPM7 (Transient Receptor Potential Cation Channel Subfamily M Member 7), a été identifiée comme surexprimée de nombreux cancers, tels que le cancer du sein, du colon, des poumons ou encore dans le glioblastome. Notre équipe a été une des premières à démontrer la surexpression de TRPM7 dans les tissus cancéreux pancréatiques ainsi que son rôle dans la migration et l'invasion cellulaire. Toutefois, si le rôle du canal TRPM7 dans ces processus a été étudié, l'implication du domaine kinase dans le cancer du pancréas n'est toujours pas décrite. Ce travail a pour objectif d'élucider in vitro son rôle dans les capacités de migration, d'nvasion et de transition épithélio-mésenchymateuse (TEM) des cellules cancéreuses pancréatiques. Les cellules cancéreuses humaines pancréatiques PANC-1 et MIA PaCa-2 ont été modifiées par CRISPR-Cas9 pour obtenir un modèle de délétion endogène du domaine kinase de TRPM7 (ΔK). Nous avons caractérisé ces modèles, en démontrant tout d'abord que l'absence du domaine modifie la sensibilité du canal au Mg2+ lié à l'ATP sans modifier sa sensibilité au Mg2+ libre ni son activité. La diminution de l'expression du domaine kinase entraîne une diminution de la migration et également de l'invasion des cellules PANC-1. Nous avons également montré que la délétion du domaine kinase entraînait une augmentation de l'expression de la cadhérine-E ainsi qu'une diminution de l'expression de la vimentine. Nos résultats in vivo démontrent également que le domaine kinase de TRPM7 dans les PANC-1 est impliqué dans la croissance tumorale. A l'inverse, lors de la diminution de l'expression du domaine kinase de TRPM7 dans les MIA PaCa-2, nous observons une augmentation de la migration et de l'nvasion. En étudiant différentes protéines décrites dans les mécanismes d'invasion et de migration, nous observons une diminution de la phosphorylation de la protéine paxiline ainsi que l'expression des protéines Rac dans nos deux modèles. Ces premiers résultats démontrent pour la première fois le rôle du domaine kinase de TRPM7 dans les propriétés de migration et d'invasion des cellules humaines cancéreuses pancréatiques. En continuant nos travaux, nos résultats suggèrent que le domaine kinase de TRPM7 pourrait être un marqueur d'agressivité et une potentielle cible thérapeutique dans certaines formes d'ACP